BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells From Ferroptosis
- 1 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 77 (5) , 1647-1658
Abstract
Aldosterone-producing adenomas (APAs) are a major cause of primary aldosteronism. Somatic mutations in ion channels and transporters drive the aldosterone overproduction in the majority of APAs with mutations in the KCNJ5 G protein-coupled potassium channel predominating in most reported populations. Our objective was to gain insight into biological mechanisms of APA tumorigenesis by comparing transcriptomes of APAs of distinct sizes by mRNA sequencing analysis (9 APAs with adenoma diameter ≥30 mm versus 12 APAs ≤10 mm). Genes with significantly altered expression levels between these 2 groups were identified in APAs with no mutation detected (348 genes) and with a KCNJ5 mutation (155 genes). We validated the differential expression of 10 genes with a known function related to cell death and proliferation in an expanded sample set of 71 APAs by real-time quantitative polymerase chain reaction (58 macro-APAs, diameter ≥10 mm; 13 micro-APAs, diameter BEX1 that was upregulated in micro-APAs relative to macro-APAs (2.76-fold, P P P =0.007). Compared with control cells, stable expression of BEX1 in human adrenocortical cells did not alter cell cycle progression or sensitivity to apoptosis but conferred protection from ferroptosis ( P BEX1 in the pathogenesis of APAs.Keywords
This publication has 49 references indexed in Scilit:
- Somatic CACNA1H Mutation As a Cause of Aldosterone-Producing AdenomaHypertension, 2020
- A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenomaEuropean Journal of Endocrinology, 2019
- Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White AmericansThe Journal of Clinical Endocrinology & Metabolism, 2018
- Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohortThe Lancet Diabetes & Endocrinology, 2017
- The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2016
- Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertensionNature Genetics, 2013
- Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronismNature Genetics, 2013
- Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertensionNature Genetics, 2013
- Potassium Channel Mutant KCNJ5 T158A Expression in HAC-15 Cells Increases Aldosterone SynthesisEndocrinology, 2012
- K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary HypertensionScience, 2011